Skip to main content

"Vi har registreret, at du besøger siden fra {0}. Vil du skifte sprog for at se indhold, der er tilpasset dig?"

->

Bloodstream infections

Reduce the risk of infection for all vascular access devices

Every IV access is at potential risk of infection, dislodgement, skin damage and other complications. These can lead to patient discomfort and pain, longer hospital stays, additional therapy and surgical procedures — or even have consequences on mortality.

Prevent bloodstream infections with solutions designed to secure and protect every IV catheter — from insertion to removal.

Img IV Care_web_antimicrobial-hero_1200x350.jpg
Overview Our solutions Product resources Evidence and guidance Support resources Contact us
På denne side...
Overview
Our solutions
Product resources
Evidence and guidance
Support resources
Contact us

Stop bloodstream infections before they start

IV therapy is a critical and fundamental part of patient care. While infusion therapy is a common way to deliver fluids and other types of medications, it comes with risks.

In fact, catheter-associated bloodstream infections (CABSIs) can occur at the time of the initial insertion or anytime throughout the duration of intravenous access — creating the potential for longer hospital stays,1-5 increased care costs2,4 and higher patient mortality.2

Icon showing a microbe, germ, used for infection prevention, BSI or CIP
60% lower CRBSI rate

Our antimicrobial dressing solutions decrease the risk of BSI for your patients.6

Read our Clinical brochure
12 fewer infections per 1000 patients

When you use our antimicrobial solutions, you can minimise the time and energy devoted to managing BSI.

Cost-effective

Our antimicrobial dressings have a 98% probability of being cost-saving over standard dressings8

Explore our range of solutions to lower your patients’ risk of BSI

From transparent film dressings and strong adhesive fixation dressings to antimicrobial dressings and disinfection caps, our broad portfolio makes it easy for you to select and use the right products for every patient.

Tegaderm™ CHG klorhexidin-glukonat IV-forbinding

Tegaderm™ CHG klorhexidin-glukonat IV-forbinding

Tegaderm CHG klorhexidin-glukonat IV-forbinding kan anvendes til at dække og beskytte kateterindstikssteder samt fiksere enheder til huden.

View product

View product

Tegaderm™ Advanced I.V. forbinding

Tegaderm™ Advanced I.V. forbinding

Tegaderm Advanced forbindinger til IV-fiksering er grundigt designet til at hjælpe dig med at levere fremragende patientpleje gennem avanceret kateterfiksering, synlighed på indstiksstedet og åndbarhed. Op til 7 dages anvendelsestid og fremragende fugthåndtering, disse CVK og PICC-forbindinger tilbyder en omkostningseffektiv kateterfikseringsløsning.

View product

View product

Curos™ Desinficerende prop til nålefri membraner

Curos™ Desinficerende prop til nålefri membraner

Curos desinficerende propper skrues fast på nålefri membraner og porte, som sikrer hurtig og korrekt desinfektion. De kan blive på i op til 7 dage, hvorved membraner og porte holdes rene og beskyttede.

View product

View product

Tegaderm Antimikrobiel I.V. Advanced 9132 er en ny integreret I.V.-forbinding, der kombinerer antimikrobiel beskyttelse med et transparent vindue til kontinuerlig inspektion af indstikssted og kateterfiksering.

View product

View product

PICC/CVK Sikkerhedsanordning + Tegaderm™ Advanced I.V. forbinding

PICC/CVK Sikkerhedsanordning + Tegaderm™ Advanced I.V. forbinding

PICC/CVK sikkerhedsanordning + Tegaderm Advanced forbinding er et fikseringssystem uden suturer, der giver pålidelig PICC/CVK-fiksering uden at gå på kompromis med patientkomforten. Det omfatter en klæbende kateterfikseringsanordning plus en IV-forbinding til fiksering, som hjælper dig med at undgå de kliniske, økonomiske og følelsesmæssige omkostninger ved PICC/CVK-komplikationer, herunder nålestikskader.

View product

View product

Collage VAS Catheters PICC, PIV, CVC, Port different formats CER 8 600x300

Find the right catheter solution for every patient

Patients need to trust that their safety and health are always most important. However, it’s not always easy to tell which catheter is best for every scenario.

We offer three options: antimicrobial solutions, advanced securement dressings and basic protection. Contact your local representative for a free trial, so you can get a feel for how our products can help your patients.

To help you get the best results, we have created a catheter decision guide that matches medical scenarios to the best catheter for the job.

Download the guide

Evidence and guidance

Discover the latest evidence and expert guidance to reduce catheter-related bloodstream infections. Empower your practice with insights and best practices to improve patient outcomes.

Kontakt en Solventum repræsentant

Vi er her for at hjælpe! Vores team af repræsentanter kan give dig information og ressourcer til at hjælpe dig. Indsend formularen nedenfor for at tale med en Solventum repræsentant for at lære mere om dine muligheder.

Leder du efter kundesupport? Besøg siden med kundesupport.

Felter markeret med * er obligatoriske.

Venligst indtast en arbejds-e-mailadresse

 

Solventum vil bruge oplysningerne til at svare på din anmodning og i overensstemmelse med vores politik om beskyttelse af personlige oplysninger.

Vi beklager. Der opstod en fejl under indsendelsen. Prøv igen senere

There was an error processing your request. Please try again later.

References:

  1. Maki D, Mermel L. Infections due to infusion therapy. In: Bennett JV, Brachman PS, eds. Bennett & Brachman’s Hospital Infections. 4th ed. Philadelphia: Lippincott-Raven; 1998:689-724.
  2. Signs, CDC Vital. "Making healthcare safer: Reducing bloodstream infections." Morbidity and Mortality Weekly Report 60, no. 8 (2011): 243-248.
  3. Blot, Stijn I., Pieter Depuydt, Lieven Annemans, Dominique Benoit, Eric Hoste, Jan J. De Waele, Johan Decruyenaere, Dirk Vogelaers, Francis Colardyn, and Koenraad H. Vandewoude. "Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections." Clinical Infectious Diseases 41, no. 11 (2005): 1591-1598.
  4. Zimlichman, Eyal, Daniel Henderson, Orly Tamir, Calvin Franz, Peter Song, Cyrus K. Yamin, Carol Keohane, Charles R. Denham, and David W. Bates. "Health care–associated infections: a meta-analysis of costs and financial impact on the US health care system." JAMA internal medicine 173, no. 22 (2013): 2039-2046.
  5. Scheithauer, S., K. Lewalter, J. Schröder, A. Koch, H. Häfner, V. Krizanovic, K. Nowicki, R-D. Hilgers, and S. W. Lemmen. "Reduction of central venous line-associated bloodstream infection rates by using a chlorhexidine-containing dressing." Infection 42, no. 1 (2014): 155-159.
  6. Timsit, Jean-François, Olivier Mimoz, Bruno Mourvillier, Bertrand Souweine, Maïté Garrouste-Orgeas, Serge Alfandari, Gaétan Plantefeve et al. "Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults." American journal of respiratory and critical care medicine 186, no. 12 (2012): 1272-1278.
  7. Loveday, H. P., J. A. Wilson, J. Prieto, and M. H. Wilcox. "epic3: revised recommendation for intravenous catheter and catheter site care." Journal of Hospital Infection 92, no. 4 (2016): 346-348.
  8. National Institute for Health and Care Excellence. Medical technologies guidance [MTG25]. Tegaderm CHG IV securement dressing for central venous and arterial catheter insertion sites. Published September 2019. Accessed November 25, 2024. www.nice.org.uk/guidance/mtg25